| UniProt ID | FOXA2_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y261 | |
| Protein Name | Hepatocyte nuclear factor 3-beta | |
| Gene Name | FOXA2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 457 | |
| Subcellular Localization |
Nucleus . Cytoplasm . Shuttles between the nucleus and cytoplasm in a CRM1-dependent manner in response to insulin signaling via AKT1 is exported from the nucleus. |
|
| Protein Description | Transcription factor that is involved in embryonic development, establishment of tissue-specific gene expression and regulation of gene expression in differentiated tissues. Is thought to act as a 'pioneer' factor opening the compacted chromatin for other proteins through interactions with nucleosomal core histones and thereby replacing linker histones at target enhancer and/or promoter sites. Binds DNA with the consensus sequence 5'-[AC]A[AT]T[AG]TT[GT][AG][CT]T[CT]-3' (By similarity). In embryonic development is required for notochord formation. Involved in the development of multiple endoderm-derived organ systems such as the liver, pancreas and lungs; FOXA1 and FOXA2 seem to have at least in part redundant roles. Originally described as a transcription activator for a number of liver genes such as AFP, albumin, tyrosine aminotransferase, PEPCK, etc. Interacts with the cis-acting regulatory regions of these genes. Involved in glucose homeostasis; regulates the expression of genes important for glucose sensing in pancreatic beta-cells and glucose homeostasis. Involved in regulation of fat metabolism. Binds to fibrinogen beta promoter and is involved in IL6-induced fibrinogen beta transcriptional activation.. | |
| Protein Sequence | MLGAVKMEGHEPSDWSSYYAEPEGYSSVSNMNAGLGMNGMNTYMSMSAAAMGSGSGNMSAGSMNMSSYVGAGMSPSLAGMSPGAGAMAGMGGSAGAAGVAGMGPHLSPSLSPLGGQAAGAMGGLAPYANMNSMSPMYGQAGLSRARDPKTYRRSYTHAKPPYSYISLITMAIQQSPNKMLTLSEIYQWIMDLFPFYRQNQQRWQNSIRHSLSFNDCFLKVPRSPDKPGKGSFWTLHPDSGNMFENGCYLRRQKRFKCEKQLALKEAAGAAGSGKKAAAGAQASQAQLGEAAGPASETPAGTESPHSSASPCQEHKRGGLGELKGTPAAALSPPEPAPSPGQQQQAAAHLLGPPHHPGLPPEAHLKPEHHYAFNHPFSINNLMSSEQQHHHSHHHHQPHKMDLKAYEQVMHYPGYGSPMPGSLAMGPVTNKTGLDASPLAADTSYYQGVYSRPIMNSS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 (in isoform 2) | Phosphorylation | - | 27.33 | 24043423 | |
| 5 (in isoform 2) | Phosphorylation | - | 6.02 | 24043423 | |
| 6 | Acetylation | --MLGAVKMEGHEPS --CCCCCCCCCCCCC | 30.60 | 67205201 | |
| 6 (in isoform 2) | Phosphorylation | - | 30.60 | 24043423 | |
| 107 | Phosphorylation | AGMGPHLSPSLSPLG CCCCCCCCCCCCCCC | 14.92 | 22196886 | |
| 111 | Phosphorylation | PHLSPSLSPLGGQAA CCCCCCCCCCCHHHC | 23.55 | 22196886 | |
| 156 | Phosphorylation | KTYRRSYTHAKPPYS CCCCCCCCCCCCCCH | 19.32 | 14500912 | |
| 212 | Phosphorylation | NSIRHSLSFNDCFLK HHHHHHCCCCCCEEE | 25.64 | 23312004 | |
| 223 | Phosphorylation | CFLKVPRSPDKPGKG CEEECCCCCCCCCCC | 31.23 | 26657352 | |
| 248 | Phosphorylation | NMFENGCYLRRQKRF CCCCCCEEHHHHHCH | 12.49 | - | |
| 256 | Acetylation | LRRQKRFKCEKQLAL HHHHHCHHCHHHHHH | 45.58 | 19830003 | |
| 259 | Acetylation | QKRFKCEKQLALKEA HHCHHCHHHHHHHHH | 61.14 | 55166807 | |
| 264 | Acetylation | CEKQLALKEAAGAAG CHHHHHHHHHHCCCC | 39.43 | 19830013 | |
| 274 | Acetylation | AGAAGSGKKAAAGAQ HCCCCCCHHHHHHHH | 40.72 | 7298009 | |
| 275 | Acetylation | GAAGSGKKAAAGAQA CCCCCCHHHHHHHHH | 46.94 | 7298019 | |
| 283 | Phosphorylation | AAAGAQASQAQLGEA HHHHHHHHHHHHHHH | 17.61 | 25999147 | |
| 295 | Phosphorylation | GEAAGPASETPAGTE HHHCCCCCCCCCCCC | 45.17 | 29116813 | |
| 297 | Phosphorylation | AAGPASETPAGTESP HCCCCCCCCCCCCCC | 18.88 | 29116813 | |
| 301 | Phosphorylation | ASETPAGTESPHSSA CCCCCCCCCCCCCCC | 35.08 | 26657352 | |
| 303 | Phosphorylation | ETPAGTESPHSSASP CCCCCCCCCCCCCCC | 27.96 | 30206219 | |
| 306 | Phosphorylation | AGTESPHSSASPCQE CCCCCCCCCCCCCHH | 30.86 | 29116813 | |
| 307 | Phosphorylation | GTESPHSSASPCQEH CCCCCCCCCCCCHHH | 29.72 | 30206219 | |
| 309 | Phosphorylation | ESPHSSASPCQEHKR CCCCCCCCCCHHHCC | 28.31 | 30206219 | |
| 338 | Phosphorylation | SPPEPAPSPGQQQQA CCCCCCCCCCHHHHH | 43.71 | 26657352 | |
| 436 | Phosphorylation | NKTGLDASPLAADTS CCCCCCCCCCCCCCC | 21.80 | 28348404 | |
| 457 | Phosphorylation | SRPIMNSS------- CCCCCCCC------- | 38.96 | - |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 156 | T | Phosphorylation |
| - |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FOXA2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| HNF6_HUMAN | ONECUT1 | physical | 12509444 | |
| TLE1_HUMAN | TLE1 | physical | 10748198 | |
| HXD13_HUMAN | HOXD13 | physical | 25609649 | |
| SATB2_HUMAN | SATB2 | physical | 25609649 | |
| DSRAD_HUMAN | ADAR | physical | 25609649 | |
| GDE_HUMAN | AGL | physical | 25609649 | |
| DACH1_HUMAN | DACH1 | physical | 25609649 | |
| FOXN2_HUMAN | FOXN2 | physical | 25609649 | |
| HXB13_HUMAN | HOXB13 | physical | 25609649 | |
| NACC1_HUMAN | NACC1 | physical | 25609649 | |
| SALL1_HUMAN | SALL1 | physical | 25609649 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...